FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Vaughan

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Amy J Marshall; Marcus Rattray; Peter F T Vaughan
Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels.
Nicola J Webster; Kim N Green; Victoria J Settle; Chris Peers; Peter F T Vaughan
Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
Nicola J Webster; Kim N Green; Chris Peers; Peter F T Vaughan
Altered processing of amyloid precursor protein in the human neuroblastoma SH-SY5Y by chronic hypoxia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Vaughan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Amy J Marshall; Marcus Rattray; Peter F T Vaughan
Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels.
Brain research 2006;1099(1):18-24.
2004: Nicola J Webster; Kim N Green; Victoria J Settle; Chris Peers; Peter F T Vaughan
Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways.
Brain research. Molecular brain research 2004;130(1-2):161-9.
2002: Nicola J Webster; Kim N Green; Chris Peers; Peter F T Vaughan
Altered processing of amyloid precursor protein in the human neuroblastoma SH-SY5Y by chronic hypoxia.
Journal of neurochemistry 2002;83(6):1262-71.
2002: Angel Agis-Torres; Stephen G Ball; Peter F T Vaughan
Chronic treatment with nicotine or potassium attenuates depolarisation-evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Neuroscience letters 2002;331(3):167-70.
2002: Ian F Smith; John P Boyle; Peter F T Vaughan; Hugh A Pearson; Richard Frank Cowburn; Chris Peers
Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation.
Brain research 2002;949(1-2):105-11.
2002: Leigh D Plant; John P Boyle; Natasha M Thomas; Nick J Hipkins; Eirikur Benedikz; Nigel M Hooper; Zaineb Henderson; Peter F T Vaughan; Chris Peers; Richard Frank Cowburn; Hugh A Pearson
Presenilin-1 mutations alter K+ currents in the human neuroblastoma cell line, SH-SY5Y.
Neuroreport 2002;13(12):1553-6.
2002: Canet Rosa; Mark Anderton; Nigel M Hooper; Anthony J Turner; Peter F T Vaughan
Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase C(alpha), src-tyrosine kinase and extracellular signal-regulated kinase but not phospholipase C.
Brain research. Molecular brain research 2002;102(1-2):62-72.
2001: Ian F Smith; John P Boyle; Peter F T Vaughan; Hugh A Pearson; Chris Peers
Effects of chronic hypoxia on Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells.
Journal of neurochemistry 2001;79(4):877-84.
2001: Martin Ramsden; Leigh D Plant; Nicola J Webster; Peter F T Vaughan; Zaineb Henderson; Hugh A Pearson
Differential effects of unaggregated and aggregated amyloid beta protein (1-40) on K(+) channel currents in primary cultures of rat cerebellar granule and cortical neurones.
Journal of neurochemistry 2001;79(3):699-712.
2001: Nicola J Webster; Peter F T Vaughan; Chris Peers
Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Brain research. Molecular brain research 2001;89(1-2):50-7.
2001: Matthew E Hartness; JA Wade; John H Walker; Peter F T Vaughan
Overexpression of the myristoylated alanine-rich C kinase substrate decreases uptake and K(+)-evoked release of noradrenaline in the human neuroblastoma SH-SY5Y.
The European journal of neuroscience 2001;13(5):925-34.
2001: D J Roberts; N Khan; RL McDonald; Nicola J Webster; Chris Peers; Peter F T Vaughan
Inhibition of depolarisation-evoked [(3)H]noradrenaline release from SH-SYFY human neuroblastoma cells by muscarinic (M1) receptors is not mediated by changes in [Ca(2+)].
Brain research. Molecular brain research 2001;87(1):81-91.
1999: K Danks; JA Wade; Trevor F C Batten; John H Walker; Stephen G Ball; Peter F T Vaughan
Redistribution of F-actin and large dense-cored vesicles in the human neuroblastoma SH-SY5Y in response to secretagogues and protein kinase Calpha activation.
Brain research. Molecular brain research 1999;64(2):236-45.
1998: JA Wade; Peter F T Vaughan; Chris Peers
Hypoxia enhances [3H]noradrenaline release evoked by nicotinic receptor activation from the human neuroblastoma SH-SY5Y.
Journal of neurochemistry 1998;71(4):1482-9.
1998: K Danks; John H Walker; Peter F T Vaughan
The effect of cytochalasin D and colcemid on noradrenaline release in the human neuroblastoma SH-SY5Y.
Biochemical Society transactions 1998;26(2):S111.
1998: X M Ou; PM Partoens; Jun Ming Wang; John H Walker; K Danks; Peter F T Vaughan; Werner P De Potter
The storage of noradrenaline, neuropeptide Y and chromogranins in and stoichiometric release from large dense cored vesicles of the undifferentiated human neuroblastoma cell line SH-SY5Y.
International journal of molecular medicine 1998;1(1):105-12.
1997: RL McDonald; D J Roberts; A C Palmer; Stephen G Ball; Peter F T Vaughan; Chris Peers
Regulation of [Ca++]i in human neuroblastoma (SH-SY5Y) cells expressing recombinant rat angiotensin1A receptors by angiotensin II and carbachol.
The Journal of pharmacology and experimental therapeutics 1997;281(3):1257-63.
1997: A R Goodall; K Danks; John H Walker; Stephen G Ball; Peter F T Vaughan
Occurrence of two types of secretory vesicles in the human neuroblastoma SH-SY5Y.
Journal of neurochemistry 1997;68(4):1542-52.
1997: A R Goodall; Neil Turner; John H Walker; Stephen G Ball; Peter F T Vaughan
Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells.
Journal of neurochemistry 1997;68(1):392-401.
1996: Neil Turner; John H Walker; Stephen G Ball; Peter F T Vaughan
Down-regulation or long-term inhibition of protein kinase C (PKC) reduces noradrenaline release evoked via either PKC-dependent or PKC-independent pathways in human SH-SY5Y neuroblastoma cells.
Neuroscience letters 1996;220(1):37-40.
1996: RL McDonald; Peter F T Vaughan; Chris Peers
Neuropeptide Y elevates intracellular Ca2+ and evokes noradrenaline release in SH-SY5Y cells.
Neuroreport 1996;7(18):2913-6.
1996: B Rist; Oliver Zerbe; N Ingenhoven; Leonardo Scapozza; Chris Peers; Peter F T Vaughan; RL McDonald; H A Wieland; Annette G Beck-Sickinger
Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor.
FEBS letters 1996;394(2):169-73.
1996: K Danks; John H Walker; Peter F T Vaughan
The occurrence of noradrenaline and neuropeptide Y in large dense-cored vesicles in the human neuroblastoma SH-SY5Y.
Biochemical Society transactions 1996;24(3):428S.
1996: A R Goodall; John H Walker; Peter F T Vaughan
Translocation of the PKC isoforms present in the human neuroblastoma, SH-SY5Y, following short-term treatment with the phorbol ester, TPA.
Biochemical Society transactions 1996;24(3):427S.
1996: Neil Turner; John H Walker; Peter F T Vaughan
The effect of down-regulation and long-term inhibition of protein kinase C on noradrenaline secretion in the neuroblastoma cell line SH-SY5Y.
Biochemical Society transactions 1996;24(3):426S.
1996: S Blanchard; J L Barwise; V Gerke; A Goodall; Peter F T Vaughan; John H Walker
Annexins in the human neuroblastoma SH-SY5Y: demonstration of relocation of annexins II and V to membranes in response to elevation of intracellular calcium by membrane depolarisation and by the calcium ionophore A23187.
Journal of neurochemistry 1996;67(2):805-13.
1996: Neil Turner; John H Walker; Stephen G Ball; Peter F T Vaughan
Phorbol ester-enhanced noradrenaline secretion correlates with the presence and activity of protein kinase C-alpha in human SH-SY5Y neuroblastoma cells.
Journal of neurochemistry 1996;66(6):2381-9.
1995: RL McDonald; Peter F T Vaughan; Annette G Beck-Sickinger; Chris Peers
Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue.
Neuropharmacology 1995;34(11):1507-14.
1995: RL McDonald; Anthony J Balmforth; AC Palmer; Stephen G Ball; Chris Peers; Peter F T Vaughan
The effect of the angiotensin II (AT1A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on noradrenaline release and changes in intracellular calcium.
Neuroscience letters 1995;199(2):115-8.
1995: RL McDonald; Annette G Beck-Sickinger; B Rist; Peter F T Vaughan; Chris Peers
Low potency inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by [Ala31]NPY, an L-alanine substituted analogue of neuropeptide Y.
Neuroscience letters 1995;190(3):179-82.
1995: Peter F T Vaughan; D F Kaye; Stephen G Ball; Helen L Reeve; Chris Peers
The effect of barium on [3H]noradrenalin release from the human neuroblastoma SH-SY5Y.
The European journal of neuroscience 1995;7(5):875-80.
1995: Helen L Reeve; Peter F T Vaughan; Chris Peers
Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptors.
Neuropharmacology 1995;34(3):319-26.
1995: Helen L Reeve; Peter F T Vaughan; Chris Peers
Enhancement of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by phorbol esters with and without activation of protein kinase C.
Pflügers Archiv : European journal of physiology 1995;429(5):729-37.
1995: A R Goodall; John H Walker; Peter F T Vaughan
Identification of vesicular proteins in the human neuroblastoma cell line, SH-SY5Y.
Biochemical Society transactions 1995;23(1):50S.
1994: RL McDonald; Peter F T Vaughan; Chris Peers
Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.
British journal of pharmacology 1994;113(2):621-7.
1994: C M O'Neill; Stephen G Ball; Peter F T Vaughan
Effects of ischaemic conditions on uptake of glutamate, aspartate, and noradrenaline by cell lines derived from the human nervous system.
Journal of neurochemistry 1994;63(2):603-11.
1994: RL McDonald; D F Kaye; Helen L Reeve; Stephen G Ball; Chris Peers; Peter F T Vaughan
Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y.
Biochemical pharmacology 1994;48(1):23-30.
1994: Helen L Reeve; Peter F T Vaughan; Chris Peers
Calcium channel currents in undifferentiated human neuroblastoma (SH-SY5Y) cells: actions and possible interactions of dihydropyridines and omega-conotoxin.
The European journal of neuroscience 1994;6(6):943-52.
1994: R E Allchin; Trevor F C Batten; Peter N McWilliam; Peter F T Vaughan
Electrical stimulation of the vagus increases extracellular glutamate recovered from the nucleus tractus solitarii of the cat by in vivo microdialysis.
Experimental physiology 1994;79(2):265-8.
1994: Neil Turner; Martin Rumsby; John H Walker; F A McMorris; Stephen G Ball; Peter F T Vaughan
A role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K(+)- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
The Biochemical journal 1994;297 ( Pt 2)():407-13.
1993: B Rana; S O McMorn; Helen L Reeve; C N Wyatt; Peter F T Vaughan; Chris Peers
Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine.
European journal of pharmacology 1993;250(2):247-51.
1993: Peter F T Vaughan; D F Kaye; R McDonald; Helen L Reeve; Stephen G Ball; Chris Peers
Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y.
Biochemical Society transactions 1993;21(4):420S.
1993: Alistair Hall; S E Bryson; Peter F T Vaughan; Stephen G Ball; Anthony J Balmforth
Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture.
British journal of pharmacology 1993;110(2):681-6.
1993: S Blanchard; John H Walker; Peter F T Vaughan
Expression of annexins in the human neuroblastoma SH-SY5Y.
Biochemical Society transactions 1993;21 ( Pt 3)(3):315S.
1993: C M Boustead; A J Kenny; Peter F T Vaughan; John H Walker
Localization of annexins V and VI in the porcine nervous system.
Biochemical Society transactions 1993;21 ( Pt 3)(3):292S.
1993: Neil Turner; John H Walker; Peter F T Vaughan
Protein kinase C subtypes associated with the regulation of noradrenaline release in human SH-SY5Y neuroblastoma cells.
Biochemical Society transactions 1993;21 ( Pt 3)(3):249S.
1993: Peter F T Vaughan; D F Kaye; Helen L Reeve; Stephen G Ball; Chris Peers
Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y.
Journal of neurochemistry 1993;60(6):2159-66.
1993: Peter F T Vaughan; M G Murphy; Stephen G Ball
Effect of inhibitors of eicosanoid metabolism on release of [3H]noradrenaline from the human neuroblastoma, SH-SY5Y.
Journal of neurochemistry 1993;60(4):1365-71.
1992: J Gould; Helen L Reeve; Peter F T Vaughan; Chris Peers
Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells.
Neuroscience letters 1992;145(2):201-4.
1992: N P Murphy; J G McCormack; Stephen G Ball; Peter F T Vaughan
The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
The Biochemical journal 1992;282 ( Pt 3)():645-50.
1992: Helen L Reeve; Peter F T Vaughan; Chris Peers
Glibenclamide inhibits a voltage-gated K+ current in the human neuroblastoma cell line SH-SY5Y.
Neuroscience letters 1992;135(1):37-40.
1991: N P Murphy; Peter F T Vaughan; Stephen G Ball; J G McCormack
The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y.
Journal of neurochemistry 1991;57(6):2116-23.
1991: M dos S Medeiros; Anthony J Balmforth; Peter F T Vaughan; Anthony J Turner
Hydrolysis of atrial and brain natriuretic peptides by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
Neuroendocrinology 1991;54(3):295-302.
1991: N P Murphy; Stephen G Ball; Peter F T Vaughan
The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
Neuroscience letters 1991;129(2):229-32.
1991: N P Murphy; Stephen G Ball; Peter F T Vaughan
Potassium- and carbachol-evoked release of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y.
Journal of neurochemistry 1991;56(5):1810-5.
1991: M L Ong; S G Ball; Peter F T Vaughan
Regulation of noradrenaline release from rat occipital cortex tissue chops by alpha 2-adrenergic agonists.
Journal of neurochemistry 1991;56(4):1387-93.
1990: M dos S Medeiros; Anthony J Balmforth; Peter F T Vaughan; A J Kenny; Anthony J Turner
Hydrolysis of natriuretic peptides by the human astrocytoma clone D384.
Biochemical Society transactions 1990;18(5):888-9.
1990: N P Murphy; Stephen G Ball; Peter F T Vaughan
Potassium- and carbachol-evoked released of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y.
Biochemical Society transactions 1990;18(3):436-7.
1990: C M O'Neill; Stephen G Ball; Peter F T Vaughan
Effects of ischaemic conditions on the uptake of catecholamine and amino acid neurotransmitters.
Biochemical Society transactions 1990;18(3):435-6.
1990: Peter F T Vaughan; Stephen G Ball
The effect of unsaturated fatty acids on sodium nitroprusside stimulation of guanylate cyclase in the human astrocytoma clone, D384, and the human neuroblastoma clone, NB1-G.
Biochemical pharmacology 1990;39(3):599-605.
1989: M D Woods; R. Ian Freshney; S G Ball; Peter F T Vaughan
Regulation of cyclic AMP formation in cultures of human foetal astrocytes by beta 2-adrenergic and adenosine receptors.
Journal of neurochemistry 1989;53(3):864-9.
1989: Anthony J Balmforth; K Yasunari; Peter F T Vaughan; S G Ball
Glucocorticoids modify differentially dopamine- and prostaglandin E1-mediated cyclic AMP formation by the cultured human astrocytoma clone D384.
Journal of neurochemistry 1989;52(5):1613-8.
1988: Anthony J Balmforth; K Yasunari; Peter F T Vaughan; S G Ball
Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
Journal of neurochemistry 1988;51(5):1510-5.
1988: M D Woods; R. Ian Freshney; G Pilkington; Peter F T Vaughan
Expression of receptors, linked to cyclic AMP formation by cultures of human fetal astrocytes.
Biochemical Society transactions 1988;16(4):432-3.
1986: Anthony J Balmforth; S G Ball; R. Ian Freshney; D I Graham; H B McNamee; Peter F T Vaughan
D-1 dopaminergic and beta-adrenergic stimulation of adenylate cyclase in a clone derived from the human astrocytoma cell line G-CCM.
Journal of neurochemistry 1986;47(3):715-9.